Fluticasone Propionate; Salm · 3 active FDA presentation rows for this drug
Brand: AIRDUO RESPICLICK
FDA lists Fluticasone Propionate; Salm as To Be Discontinued (Teva Pharmaceuticals USA, Inc.).
No availability text on this FDA row.
Fluticasone Propionate; Salmeterol Xinafoate Powder: To Be Discontinued
FDA availability text is not recorded on this row. 3 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Fluticasone Propionate; Salmeterol Xinafoate Powder
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Dosage Form
- Powder
- Presentation
- AirDuo RespiClick, Powder, 232 ug; 14 ug (NDC 59310-822-06)
- Package NDC
- 59310-822-06
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Jun 13, 2025
- Last Updated
- Jun 13, 2025
- Therapeutic Category
- Pulmonary/Allergy
Row fields from the FDA Drug Shortages database via openFDA.
Full Drug Profile
fluticasone
Side effects, interactions, warnings & more
Nearby, Other Fluticasone Shortage Records
Azelastine Hydrochloride; Fluticasone Propionate Nasal Spray
Mylan Pharmaceuticals Inc., a Viatris Company
Nasal Spray
Fluticasone Propionate; Salmeterol Xinafoate Powder
Teva Pharmaceuticals USA, Inc.
Powder
Fluticasone Propionate; Salmeterol Xinafoate Powder
Teva Pharmaceuticals USA, Inc.
Powder